AtriCure (NASDAQ:ATRC – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Tuesday. ATRC has been the topic of several other reports. Canaccord Genuity Group lowered their price target on AtriCure from $120.00 to $88.00 and set a “buy” rating on the stock in a […]